Profile data is unavailable for this security.
About the company
ResMed Inc. is a holding company. The Company is engaged in the development, manufacturing, distribution and marketing of medical devices and cloud-based software applications that diagnose, treat and manage respiratory disorders, including sleep disordered breathing (SDB), chronic obstructive pulmonary disease (COPD), neuromuscular disease and other diseases. The Company operates through two segments: Sleep and Respiratory Care segment, and the Software-as-a-Service (SaaS) segment. SDB includes obstructive sleep apnea (OSA) and other respiratory disorders that occur during sleep. Its cloud-based software digital health applications, along with its devices, are designed to provide connected care to improve patient outcomes. The Company's portfolio of products includes devices, diagnostic products, mask systems, headgear and other accessories, dental devices, portable oxygen concentrators (POCs) and cloud-based software informatics solutions.
- Revenue in USD (TTM)3.03bn
- Net income in USD679.90m
- Incorporated1994
- Employees7.77k
- LocationResmed Inc9001 Spectrum Center BlvdSAN DIEGO 92123-1438United StatesUSA
- Phone+1 (858) 746-2400
- Fax+1 (302) 636-5454
- Websitehttps://www.resmed.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Varian Medical Systems, Inc. | 3.17bn | 273.00m | 15.83bn | 10.06k | 58.27 | 7.63 | 59.41 | 5.00 | 2.98 | 2.94 | 34.61 | 22.77 | 0.7395 | 3.35 | 2.91 | -- | 6.38 | 7.99 | 11.38 | 14.28 | 43.47 | 42.96 | 8.62 | 10.16 | 1.12 | -- | 0.1455 | -- | -1.76 | 4.93 | -8.96 | -2.68 | -- | -- |
| Steris PLC | 3.02bn | 422.29m | 16.62bn | 13.00k | 39.52 | 4.55 | 26.55 | 5.50 | 4.93 | 4.93 | 35.26 | 42.78 | 0.5661 | 6.64 | 5.94 | 232,485.80 | 7.90 | 4.97 | 8.62 | 5.44 | 43.38 | 41.48 | 13.96 | 9.09 | 2.00 | 17.68 | 0.2179 | 41.25 | 8.94 | 10.37 | 34.06 | 24.72 | 20.27 | 10.01 |
| Teleflex Incorporated | 2.51bn | 367.01m | 17.34bn | 14.40k | 47.93 | 5.36 | 29.33 | 6.91 | 7.77 | 7.78 | 53.05 | 69.50 | 0.3896 | 2.34 | 6.37 | 174,092.30 | 5.70 | 5.51 | 6.19 | 6.18 | 53.44 | 55.10 | 14.64 | 12.85 | 1.88 | 8.26 | 0.3967 | 21.63 | 6.00 | 7.12 | 135.19 | 19.40 | 8.73 | 0.00 |
| Insulet Corporation | 867.69m | 28.87m | 17.42bn | 1.35k | 604.18 | 29.25 | 257.38 | 20.08 | 0.4374 | 0.4374 | 13.38 | 9.03 | 0.5825 | 2.90 | 10.65 | 642,736.30 | 1.94 | -3.14 | 2.15 | -3.62 | 64.00 | 61.42 | 3.33 | -4.19 | 5.91 | 1.94 | 0.6077 | -- | 30.93 | 26.12 | 252.37 | -- | 71.60 | -- |
| Cooper Companies Inc | 2.44bn | 272.40m | 17.72bn | 12.00k | 60.72 | 4.34 | 32.05 | 7.26 | 5.47 | 5.59 | 49.11 | 76.58 | 0.3778 | 1.60 | 5.71 | 203,408.30 | 4.22 | 6.60 | 5.00 | 7.44 | 64.15 | 63.11 | 11.16 | 15.05 | 0.6436 | 7.26 | 0.3334 | 0.8777 | 4.76 | 9.09 | 30.01 | 11.30 | 4.18 | 0.00 |
| Hologic, Inc. | 3.78bn | 1.12bn | 17.99bn | 5.81k | 16.65 | 6.66 | 12.10 | 4.76 | 4.20 | 4.20 | 14.27 | 10.51 | 0.5538 | 3.63 | 4.50 | 649,535.60 | 16.29 | 4.23 | 19.61 | 5.13 | 59.67 | 54.66 | 29.41 | 9.48 | 1.47 | 10.25 | 0.5304 | 0.00 | 12.15 | 6.90 | 661.53 | 53.33 | 11.84 | -- |
| West Pharmaceutical Services Inc. | 2.04bn | 311.70m | 20.79bn | 8.20k | 68.23 | 12.09 | 51.73 | 10.20 | 4.12 | 4.12 | 26.94 | 23.26 | 0.8566 | 5.05 | 5.91 | 248,451.20 | 12.40 | 9.48 | 14.85 | 11.20 | 34.85 | 32.49 | 14.48 | 10.89 | 2.11 | -- | 0.1295 | 21.64 | 7.13 | 5.30 | 18.25 | 13.72 | 2.43 | 8.27 |
| Zimmer Biomet Holdings Inc | 7.06bn | -151.90m | 30.37bn | 19.90k | -- | 2.56 | 34.85 | 4.30 | -0.7559 | -0.7559 | 34.06 | 57.27 | 0.2923 | 0.87 | 5.67 | 355,020.10 | -0.6198 | 1.45 | -0.7084 | 1.60 | 70.11 | 70.72 | -2.12 | 4.69 | 1.17 | 9.17 | 0.411 | 53.74 | 0.6215 | 11.30 | 405.10 | 9.46 | 16.05 | 1.76 |
| ResMed Inc. | 3.03bn | 679.90m | 30.69bn | 7.77k | 45.44 | 11.45 | 36.70 | 10.13 | 4.66 | 4.66 | 20.76 | 18.49 | 0.6901 | 3.03 | 6.20 | 389,691.10 | 15.50 | 12.62 | 17.81 | 14.75 | 58.29 | 57.71 | 22.45 | 18.46 | 1.80 | 15.53 | 0.2828 | 45.44 | 13.44 | 11.99 | 51.41 | 11.99 | 8.05 | 6.85 |
| DexCom, Inc. | 1.82bn | 231.10m | 31.75bn | 3.90k | 136.88 | 21.17 | 108.70 | 17.44 | 2.42 | 2.42 | 19.00 | 15.62 | 0.605 | 3.82 | 6.02 | 466,820.50 | 7.68 | -1.96 | 8.91 | -2.31 | 66.32 | 65.65 | 12.69 | -2.24 | 6.00 | 5.92 | 0.5313 | -- | 43.08 | 41.61 | 179.29 | -- | 61.86 | -- |
| Align Technology, Inc. | 2.29bn | 1.74bn | 34.80bn | 14.53k | 20.07 | 11.47 | 19.03 | 15.22 | 21.99 | 21.99 | 28.94 | 38.47 | 0.6761 | 6.08 | 3.95 | 157,412.80 | 51.38 | 18.60 | 72.82 | 26.41 | 71.04 | 74.16 | 75.99 | 19.47 | 1.20 | -- | 0.00 | 0.00 | 22.39 | 25.87 | 10.63 | 24.87 | 44.10 | -- |
| Baxter International Inc | 11.53bn | 733.00m | 40.29bn | 50.00k | 55.97 | 4.70 | 25.81 | 3.49 | 1.41 | 1.76 | 22.42 | 16.77 | 0.6167 | 3.67 | 6.05 | 230,620.00 | 3.97 | 9.52 | 4.74 | 11.99 | 41.12 | 42.29 | 6.43 | 16.39 | 2.06 | 13.44 | 0.4299 | 24.49 | 2.37 | 1.17 | -40.00 | 12.04 | -18.18 | -16.14 |
Data as of Nov 23 2020. Currency figures normalised to Resmed Inc's reporting currency: US Dollar USD
40.34%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| The Vanguard Group, Inc.as of 30 Sep 2020 | 14.97m | 10.33% |
| BlackRock Fund Advisorsas of 30 Sep 2020 | 8.71m | 6.01% |
| WCM Investment Management LLCas of 30 Sep 2020 | 8.69m | 6.00% |
| SSgA Funds Management, Inc.as of 30 Sep 2020 | 6.59m | 4.55% |
| Capital Research & Management Co. (World Investors)as of 30 Sep 2020 | 5.34m | 3.68% |
| Fidelity Management & Research Co. LLCas of 30 Sep 2020 | 4.37m | 3.02% |
| Baillie Gifford & Co.as of 30 Sep 2020 | 3.13m | 2.16% |
| Geode Capital Management LLCas of 30 Sep 2020 | 2.48m | 1.71% |
| Northern Trust Investments, Inc.(Investment Management)as of 30 Sep 2020 | 2.25m | 1.55% |
| Invesco Advisers, Inc.as of 30 Sep 2020 | 1.91m | 1.32% |
More ▼
Data from 30 Sep 2020 - 30 Sep 2020Source: FactSet Research Systems Inc.
